Neurocrine Biosciences (NBIX) Other Non Operating Income (2010 - 2022)
Neurocrine Biosciences (NBIX) posted quarterly Other Non Operating Income of -$70.0 million for Q2 2022, down 280.43% on a QoQ basis from -$18.4 million in Q4 2020.
Neurocrine Biosciences (NBIX) Other Non Operating Income (2010 - 2022) Analysis & Trends
Neurocrine Biosciences has reported Other Non Operating Income for 8 years, with the latest figure at -$70.0 million in Q2 2022.
- Other Non Operating Income for Q2 2022 came in at -$70.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was -$70.0 million (changed 0.0% YoY), and the FY2022 annual result was -$70.0 million, changed N/A from the prior year.
- Other Non Operating Income eased to -$70.0 million in Q2 2022, from -$18.4 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at -$18.4 million in Q4 2020 and troughed at -$70.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -70.00 Mn |
| Dec 31, 2020 | -18.40 Mn |
| Dec 31, 2015 | 20,000.00 |
| Dec 31, 2014 | 15,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Dec 31, 2013 | 15,000.00 |
| Sep 30, 2013 | -5,000.00 |
| Jun 30, 2013 | 4,000.00 |
| Mar 31, 2013 | 2,000.00 |
| Dec 31, 2012 | 5,000.00 |
| Sep 30, 2012 | 2,000.00 |
| Jun 30, 2012 | 5,000.00 |
| Mar 31, 2012 | 2,000.00 |
| Dec 31, 2011 | 5,000.00 |
| Sep 30, 2011 | 18,000.00 |
| Jun 30, 2011 | 5,000.00 |
| Mar 31, 2011 | 8,000.00 |
| Dec 31, 2010 | 996,000.00 |
| Jun 30, 2010 | 35,000.00 |